Modification of Three-Phase Drug Release Mode of Octreotide PLGA Microspheres by Microsphere-Gel Composite System

In order to obtain sustained release of biodegradable microspheres, the purpose of this study was to design and characterize an injectable octreotide microsphere-gel composite system. The octreotide microspheres were prepared by phase separation method, which used PLGA as a carrier material, dimethyl silicone oil as a phase separation reagent, and n-heptane-Span 80 as a hardener. In addition, we used poloxamer 407 (PL 407) and poloxamer 188 (PL 188) as the thermosensitive gel matrix material. The composite system was obtained by scattering octreotide microspheres in a poloxamer gel. In vitro data showed that the release time of the composite system could last for about 50 days. Because of the blocking and control actions of the poloxamer gel, the initial burst release was significantly reduced and the plateau phase was eliminated. Pharmacokinetic data showed that the burst release of the composite system was significantly less than that of the microspheres, i.e., Cmax1 was reduced by about half. From day 2 to day 50, higher plasma concentration levels and more stable drug release behavior were exhibited. In addition, the good biocompatibility of the composite system in vivo was also demonstrated by hematoxylin-eosin (HE) staining. Therefore, the octreotide microsphere-gel composite system will be a new direction for hydrophilic polypeptide/protein-loaded sustained release dosage forms with high pharmacological activity.

[1]  Yingge Zhang,et al.  To reduce premature drug release while ensuring burst intracellular drug release of solid lipid nanoparticle-based drug delivery system with clathrin modification. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[2]  Qingdi Zhu,et al.  Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. , 2018, Materials science & engineering. C, Materials for biological applications.

[3]  Yu-chun Wu,et al.  Glycol chitin/PAA hydrogel composite incorporated bio-functionalized PLGA microspheres intended for sustained release of anticancer drug through intratumoral injection , 2018, Journal of biomaterials science. Polymer edition.

[4]  E. Allémann,et al.  Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[5]  M. Hashemi,et al.  Optimization of PLGA formulation containing protein or peptide-based antigen: Recent advances. , 2018, Journal of biomedical materials research. Part A.

[6]  Xuesi Chen,et al.  Precision-guided long-acting analgesia by Gel-immobilized bupivacaine-loaded microsphere , 2018, Theranostics.

[7]  H. B. Zhang,et al.  Comparison of the degradation behavior of PLGA scaffolds in micro-channel, shaking, and static conditions. , 2018, Biomicrofluidics.

[8]  L. Irusta,et al.  Miscibility and degradation of polymer blends based on biodegradable poly(butylene adipate-co-terephthalate) , 2018 .

[9]  B. Wiedenmann,et al.  Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines , 2018, Front. Endocrinol..

[10]  G. Gargala,et al.  Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum , 2018, PloS one.

[11]  Xin Pan,et al.  Anhydrous reverse micelle lecithin nanoparticles/PLGA composite microspheres for long-term protein delivery with reduced initial burst. , 2018, Colloids and surfaces. B, Biointerfaces.

[12]  X. Jing,et al.  Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease , 2018, Drug delivery.

[13]  J. Panyam,et al.  Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer , 2017, Drug Delivery and Translational Research.

[14]  A. Silva,et al.  Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders , 2018, Pharmaceutical Research.

[15]  Steven R. Little,et al.  The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly(lactic-co-glycolic acid) matrices. , 2017, Biomaterials.

[16]  T. Haraguchi,et al.  Effect of Self-healing Encapsulation on the Initial Burst Release from PLGA Microspheres Containing a Long-Acting Prostacyclin Agonist, ONO-1301. , 2017, Chemical & pharmaceutical bulletin.

[17]  G. Sadowski,et al.  Drug release kinetics and mechanism from PLGA formulations , 2016 .

[18]  A. Akkari,et al.  Poloxamer 407/188 binary thermosensitive hydrogels as delivery systems for infiltrative local anesthesia: Physico-chemical characterization and pharmacological evaluation. , 2016, Materials science & engineering. C, Materials for biological applications.

[19]  Kristofer J. Thurecht,et al.  Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading , 2016, Front. Pharmacol..

[20]  F. Papadimitrakopoulos,et al.  Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[21]  J. Siepmann,et al.  Importance of PLGA microparticle swelling for the control of prilocaine release , 2015 .

[22]  Christine Vauthier,et al.  Gelation and micellization behaviors of pluronic(®) F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically designed for mucosal application. , 2015, Colloids and surfaces. B, Biointerfaces.

[23]  J. Siepmann,et al.  Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Ziyu Wu,et al.  Quantitative three-dimensional analysis of poly (lactic-co-glycolic acid) microsphere using hard X-ray nano-tomography revealed correlation between structural parameters and drug burst release. , 2015, Journal of pharmaceutical and biomedical analysis.

[25]  C. van Nostrum,et al.  Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC–MS/MS , 2015, Pharmaceutical Research.

[26]  Yong-Hee Kim,et al.  Thermo-reversible injectable gel based on enzymatically-chopped low molecular weight methylcellulose for exenatide and FGF 21 delivery to treat types 1 and 2 diabetes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Y. Zhang,et al.  A new class of inhibitors of peptide sorption and acylation in PLGA. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[28]  J. Goodman,et al.  Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions , 2003, AAPS PharmSciTech.

[29]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[30]  J M Brady,et al.  Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. , 1977, Journal of biomedical materials research.